Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache.


Journal

Drugs
ISSN: 1179-1950
Titre abrégé: Drugs
Pays: New Zealand
ID NLM: 7600076

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 7 6 2020
medline: 2 1 2021
entrez: 7 6 2020
Statut: ppublish

Résumé

Galcanezumab (Emgality

Identifiants

pubmed: 32504377
doi: 10.1007/s40265-020-01329-5
pii: 10.1007/s40265-020-01329-5
doi:

Substances chimiques

Antibodies, Monoclonal, Humanized 0
galcanezumab 55KHL3P693
Calcitonin Gene-Related Peptide JHB2QIZ69Z

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

893-904

Commentaires et corrections

Type : ErratumIn

Auteurs

Lesley J Scott (LJ)

Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH